Limi®
Limi®
Therapeutic Segment: Antihyperglycemic
Generic Name: Glimepride + Metformin HCl
Indications:
For the management of patients with type 2 diabetes mellitus when diet, exercise and single agent
(glimepiride or metformin alone) do not result in adequate glycemic control.
Available as:
Tablets
- 1/500 mg
- 2/500 mg
PRESCRIBING INFORMATION
